YOLFTbeta
Eshbal Functional Food Inc.

Eshbal Functional Food Inc.

ESBL · V · Consumer Defensive / Packaged Foods

0.07CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.07
Open0.07
Day Range0.07 – 0.07
52-Week Range0.07 – 0.22
Volume40.00K
Market Cap6.24M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.04
Dividend Yield0.00%
Beta0.11
50-Day Avg0.0955
200-Day Avg0.1414

About

Eshbal Functional Food Inc. research, develops, and manufactures food products and dietary supplements Israel, North America, and Europe. The company manufactures gluten free baked products; and sugar-free products, vegan products, super-foods, dietary supplements, syrups, and dry mixes, including sweeteners and a line of low-carb products under the Eshbal du BARILI free living, Cargil, Confectioner, KOMIDA, and ZEN brand name. It offers its products through supermarkets, as well as other food retailers, health stores, and foodservice. The company was formerly known as Hakken Capital Corp. and changed its name to Eshbal Functional Food Inc. The company was founded in 1940 and is based in Vancouver, Canada.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Tomer Bar-Meir
  • Employees0
  • Headquarters609 Granville Street, Vancouver, BC, Canada, V7Y 1C3, Canada
  • Websitehttps://eshbalfoods.com

Leadership

  • Mr. Tomer Bar-MeirChief Executive Officer · b. 1980
  • Ms. Maya Katzman CPAChief Financial Officer
  • Ms. Anat ShuhamiHead of Investor Communications
  • Mr. Avi MarkusChief Commercial Officer for North America
  • Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.Corporate Secretary · b. 1973

Financials

Income Statement

Currency: USD2022-12-312023-12-312024-12-31
Total Revenue12.15M11.16M11.44M
Growth (%)--8.14%+2.55%
Cost of Revenue9.62M8.85M8.84M
Gross Profit2.53M2.31M2.60M
Gross Margin20.84%20.72%22.72%
Operating Expense2.16M2.00M2.02M
Operating Income371.00K308.00K583.00K
Operating Margin3.05%2.76%5.09%
EBITDA1.11M992.00K1.28M
EBITDA Margin9.10%8.89%11.17%
Net Income-12.00K-4.00K313.00K
Net Income Margin-0.10%-0.04%2.74%
R&D243.00K220.00K263.00K
R&D as % of Total Revenue2.00%1.97%2.30%
Interest Expense276.00K319.00K302.00K
Interest Expense % of Total Revenue2.27%2.86%2.64%

Balance Sheet

Currency: USD2022-12-312023-12-312024-12-31
Total Assets11.13M10.54M10.61M
Total Liabilities8.74M8.12M8.04M
Total Equity2.40M2.43M2.57M
Cash12.00K137.00K39.00K
Net Debt3.22M2.84M2.49M

Cash Flow

Currency: USD2022-12-312023-12-312024-12-31
Operating Cash Flow229.00K563.00K631.00K
Financing Cash Flow-313.00K-312.00K-638.00K
Capital Expenditure189.00K83.00K133.00K
Free Cash Flow40.00K480.00K498.00K
FCF to OCF17.47%85.26%78.92%

Earnings

Report DateSep 28, 2026Oct 1, 2026
EPS Estimate--
EPS Actual--
Surprise--
TimingAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap6.24M
Enterprise Value14.87M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.40
Price / Book1.40
EPS-0.04
Book Value0.0612
Revenue (TTM)15.80M
Gross Profit (TTM)3.83M
EBITDA-328.00K
Profit Margin-11.94%
Operating Margin-23.90%
Return on Equity-54.01%
Return on Assets-5.01%
Shares Outstanding83.26M
Shares Float30.83M
Beta0.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%